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Abstract
Introduction: Ankylosing Spondylitis (AS) is characterised by limitations in physical function. The Bath Ankylosing
Spondylitis Functional Index (BASFI) is considered to be the gold-standard to assess physical function in AS
patients. However, the BASFI questionnaire is a self-reported outcome measure and susceptible to subjective
interpretation (under- or over-estimation). More objective outcome measures, like performance-based tests, could
provide an objective outcome measurement for the evaluation of limitations in physical function. Therefore, the
primary aim of this study was to determine the association between performance-based measures and the BASFI
questionnaire.
Methods: In this cross-sectional study 126 AS patients completed the BASFI questionnaire and eight performance-
based tests based on BASFI-items. Each test received three scores: one for performance (time or points) and a
score for exertion and pain experienced during performance (using modified Borg-scale and VAS 0-100 mm,
respectively). Linear regression analyses were used to assess the associations between the BASFI questionnaire and
performance-based tests.
Results: The univariable association between performance and BASFI-score was moderate with a R-square of 0.31
and Beta of 0.56 (p’s < 0.05). In a multivariable analysis, the association between performance, exertion and pain on
the one hand and BASFI-score on the other was assessed; R-square increased to 0.54: the Beta’s for exertion and
pain during performance were 0.38 and 0.26, respectively; the Beta for performance decreased to 0.19 (p’s < 0.05).
Conclusions: This study demonstrates that alongside actual performance, patients seem to incorporate exertion
and pain in their assessment of perceived physical function on the BASFI questionnaire. Performance-based tests
could provide an objective outcome measurement for the evaluation of physical function and give relevant new
information in addition to the BASFI questionnaire.
Introduction
Limitations in physical function due to inflammation,
pain and reduced spinal mobility are an important fea-
ture of ankylosing spondylitis (AS). Physical function is,
therefore, considered an important outcome measure
for evaluating the disease course and the effectiveness of
interventions in AS patients [1,2]. The preferred assess-
ment methods for evaluating limitations in physical
function in AS patients are self-reported outcome mea-
sures such as the Bath Ankylosing Spondylitis Func-
tional Index (BASFI) [3] or the Dougados Functional
Index (DFI) [4]. Both indexes are disease-specific out-
come parameters that have been proven to have ade-
quate clinimetric properties and to be reflective of
patients’ perspectives [5-8].* Correspondence: s.v.weely@reade.nl1Reade, Centre for Rehabilitation and Rheumatology, Dr. Jan van
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The BASFI questionnaire is currently the most widely
used instrument to assess physical function in AS
patients. A self-reported measure such as the BASFI
refers to a method in which an individual is asked to
indicate his/her perceived level of function during daily
activities, described in standardised questions [9]. An
alternative method for assessing limitations in physical
function is the use of performance-based tests. In these
measures an individual has to perform one or more spe-
cific activities that are evaluated in a standardised man-
ner, mostly time to complete the activity [9,10].
Although self-reported and performance-based mea-
sures both claim to assess the physical function domain,
numerous studies have reported only moderate relations
between both measurements. These moderate relations
were found, among others, in elderly patients, and those
with chronic low back pain and osteoarthritis [9,11-14].
It has been suggested that (time-based) performance
and self-reported measures assess different aspects of
the physical function domain [15-17]. Self-reported
measures of limitations in physical function represent
what people experience when they are performing activ-
ities rather than their true ability to be able to perform
the activities [9,11,18]. This may lead to discrepancies
between perceptions of the individual assessed using a
self-reported measure and their true ability (underesti-
mation or overestimation, e.g. due to personality traits,
language or depression) [9-11,19]. In addition, discor-
dance between observed and perceived physical function
measured with a self-reported questionnaire has been
reported in patients with AS, rheumatoid arthritis and
fibromyalgia [20,21].
Recently, we developed performance-based tests of
physical function for AS patients based on items
described in the BASFI questionnaire [22]. The perfor-
mance score (i.e. time to perform an activity or points
scored), as well as exertion and pain during performance
were measured. We reported that these tests showed
adequate to excellent test-retest reproducibility on all
test components (performance score, exertion and pain)
[22]. However, until now no information has been avail-
able on how performance-based physical function relates
to self-reported physical function as assessed with the
BASFI questionnaire. Similarly, no information is avail-
able on how exertion and pain during performance have
impact on self-reported physical function, as assessed
with the BASFI questionnaire. Therefore, the primary
aim of the present study was (i) to determine the asso-
ciation between performance-based tests and the BASFI
questionnaire in AS patients, and (ii) to determine the
association between exertion and pain during perfor-
mance and the BASFI questionnaire. The secondary aim
of this study was (iii) to determine the associations
between performance-based tests of physical function
and disease activity (as assessed with the Bath Ankylos-
ing Spondylitis Disease Activity Index; BASDAI) [23] as
well as impairments in mobility of the hips and spine
(as assessed with the Bath Ankylosing Spondylitis
Metrology Index; BASMI) [24].
Materials and methods
Patients participating in this study were recruited from a
large outpatient centre for rehabilitation and rheumatol-
ogy, Reade in Amsterdam. Enrolment took place from
May 2006 to May 2010. The following inclusion criteria
were applied: diagnosis of AS according to the modified
New York criteria [25], age of 18 years or older and suf-
ficient command of the Dutch language. Patients with
pulmonary, cardiovascular or neurological co-morbidity
affecting the patient’s ability to perform daily activities
were excluded. The study was approved by the medical
ethical committee of the Slotervaart Hospital and Reade.
All patients gave written informed consent according to
the Declaration of Helsinki.
Design and measures
A cross-sectional design was applied to determine the
associations between (i) the performance scores [22] and
the BASFI questionnaire [3,26], (ii) the performance
scores, exertion, pain and the BASFI questionnaire, and
(iii) between the performance scores and BASDAI and
BASMI, respectively. Patients completed the perfor-
mance tests, BASFI, BASDAI and BASMI within a one-
month period. It was assumed that during this period
the patient’s physical condition remained unchanged.
The same assessor measured all subjects on the perfor-
mance-based tests and was blinded for the results of the
BASFI, BASDAI and BASMI.
The eight performance-based tests based on items of
the BASFI included: climbing stairs (no. 1), bending
(no. 2), reaching up (no 3), putting on socks (no. 4),
reclining and declining from a chair (no. 5), getting up
from the floor (no. 6), looking over the shoulder (no.
7) and a physically demanding activity (no. 8) as pre-
viously described by van Weely et al. [22]. In all tests
the time taken to perform the task was measured in
seconds, except for no. 7 (looking over the shoulder)
in which the range of vision was recorded in points.
Pain and exertion experienced during performance
were assessed directly following each test using a 10-
cm horizontal visual analogue scale (VAS) and Borg’s
modified scale [27], respectively. The Borg scale is a
rating of perceived exertion and was developed to
describe a person’s perception of exertion during exer-
cise. In this way, each performance test received three
scores: a performance score (time or points) and scores
for pain and exertion as experienced during perform-
ing the test.
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We used the generally accepted BASDAI [23] as the
outcome parameter for disease activity, because com-
mon laboratory measures of inflammation have only a
limited ability to corroborate patient reported health sta-
tus or clinician observed impairments. Impairments in
spinal and hip mobility were assessed by the BASMI
[24]. This is a combined index comprising of measure-
ments of lateral spinal flexion, tragus-to-wall distance,
lumbar flexion, intermalleolar distance and cervical
rotation.
Statistical analyses
Descriptive statistics were computed by calculating
means and standard deviations (SDs) for all continuous
data and percentages for categorical data. Prior to deter-
mining the various associations with the performance-
based tests, the performance scores were transformed
into Z-scores. The association between the separate
tests (internal consistency) was established, and a total
performance score was established by calculating a
mean Z-score.
To assess the association between performance-based
tests of physical function and BASFI questionnaire, uni-
variable and multivariable linear regression analyses
were performed. Univariable analysis was performed
with performance as independent variable and the
BASFI-score as dependent variable. In multivariable ana-
lyses performance as well as exertion and pain during
performance were entered as independent variables and
the BASFI-score as dependent variable.
Univariable regression analyses were also used to
establish the associations between performance tests of
physical function and disease activity (BASDAI) as well
as between performance tests and impairments in mobi-
lity of the hips and spine (BASMI). All analyses were
performed using SPSS for Windows 18.0 (SPSS Inc, Chi-
cago, IL, USA). Statistical significance was set at the P <
0.05 level.
Results
Descriptive statistics
The study population consisted of 139 consecutive AS
patients. BASFI data were missing for 13 patients
(9.4%) and they were therefore excluded. No patients
were excluded for having pulmonary, cardiovascular or
neurological co-morbidity affecting the patient’s ability
to perform daily activities. Accordingly, 126 patients
(70.6% men) with a mean age of 45.9 years were
included in the analyses. Table 1 displays the baseline
characteristics. Disease activity was high with a mean
BASDAI (SD) of 5.2 (± 2.3). Medication was used by
80% of the study population and only 4% was treated
with TNF-blockers (biologicals) at the time of the
study. Patients’ characteristics, means and standard
deviations (SD) of the BASFI, BASDAI and BASMI are
displayed in Table 1.
Relations between the performance scores (internal
consistency)
Based on analysis for internal consistency items 1 to 6
and 8 (stair climbing, bending, reaching, putting on
socks, reclining and declining from a chair, getting up
from the floor and physically demanding activity) can be
regarded as representations of the same domain. Item 7
(looking over the shoulder) does not belong to this
domain. Inter-item correlations of items 1 to 6 and 8
with item 7 were low (0.25-0.32). Factor analysis (princi-
pal components) showed one component, with items 1
to 6 and 8 loading in the range from 0.65 to 0.85, while
item 7 loaded only 0.38. Chronbach’s alpha increased
from 0.85 to 0.87 when item 7 was deleted. Therefore,
univariable and multivariable analyses were performed
separately for items 1 to 6 plus 8, and for item 7.
Performance tests and the BASFI questionnaire
Results of the uni- and multivariable regression analyses
are shown in Table 2. The univariable association
between performance tests 1 to 6 plus 8 and BASFI-
score was moderate with a R-square of 0.31 and Beta of
0.56. In the multivariable association R-square increased
Table 1 Characteristics of 126 patients with ankylosing
spondylitis
Men % (n) 70.6 (89)
Age* (years) 45.9 ± 11.5
Symptom duration* (years) 8.1 ± 7.4
Disease duration* (years) 14.7 ± 10.0
Current medication % (n)
None 12.7 (16)
NSAIDs 61.9 (78)
Biologicals 4.0 (5)
Combination 10.3 (13)
Other# 4.0 (5)
HLA-B27+ % (n) 77.8 (98)
ESR* (mm/hour) 10.4 ± 18.4
Extra-spinal symptoms % (n)
psoriasis 4.8 (6)
uveitis 19.8 (25)
inflammatory bowel disease 4.0 (5)
arthritis 38.1 (48)
BASFI* (score 0-10) 4.9 ± 2.3
BASDAI* (score 0-10) 5.2 ± 2.3
BASMI* (score 0-10) 4.1 ± 2.0
* mean ± standard deviation
# e.g. sulfasalazine, methotrexate.
BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath
Ankylosing Spondylitis Functional Index; BASMI, Bath Ankylosing Spondylitis
Metrology Index; ESR, { Erythrocyte Sedimentation Rate NSAIDs, non-steroidal
antiinflammatory drugs.
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to 0.54: Beta’s for exertion and pain during performance
were 0.38 and 0.26, respectively, while the Beta for per-
formance decreased to 0.19 (P < 0.05).
In the analyses on performance-test 7 (looking over
the shoulder), similar results were seen. The univariable
association was moderate with a R-square of 0.39 and
Beta of 0.63. In the multivariable association R-square
increased to 0.51 and the Beta for the performance test
decreased to 0.49 (P < 0.05). The Beta for pain during
performance was 0.36 (P < 0.05); the Beta for exertion
during performance was 0.00 and not significant.
Performance tests, BASDAI and BASMI
Table 3 shows the results of the univariable associations
between performance tests and BASDAI as well as
BASMI. The results indicate that performance tests of
physical function are more strongly associated with
impairments in spinal and hip mobility (BASMI) than
with self-reported disease activity (BASDAI). The asso-
ciation between performance tests and BASDAI was low
with a R-square of 0.08 and Beta of 0.28 for tests 1 to 6
plus 8 and a R-square of 0.00 with a Beta close to zero
(-0.06; P = 0.534) for test 7. The association of the per-
formance tests with the BASMI was higher with a R-
square of 0.24 and Beta of 0.50 for tests 1 to 6 plus 8.
For test 7 R-square was 0.60 and Beta was 0.77.
Discussion
The present study shows that the association between
performance-based tests of physical function and the
BASFI questionnaire was moderate. The BASFI ques-
tionnaire has a stronger association with exertion and
pain during performance than with actual performance.
Furthermore, we have shown that the performance tests
are more strongly associated with impairments in spinal
and hip mobility (BASMI) than with disease activity
(BASDAI). This demonstrates that performance-based
tests of physical function and the BASFI questionnaire
do not measure the same aspects of the physical func-
tion domain in AS patients. Performance-based tests
seem to measure actual physical function and the BASFI
questionnaire seems to measure perceived physical func-
tion. When patients define their physical function on
the BASFI questionnaire, exertion and pain experienced
during performing activities seem to be of greater influ-
ence on the score than actual performance. Conse-
quently, performance-based tests can give additional
information on physical function and can provide an
objective outcome measurement for the evaluation of
interventions.
Performance-based measures for the evaluation of
physical function in AS patients have not been reported
previously. Moderate associations between performance-
based and self-reported measures of physical function,
such as with the BASFI questionnaire in our study, have
been found consistently in other patient groups (elderly,
chronic low back pain, osteoarthritis) [10,12-15]. Three
explanations for the moderate correlations between the
BASFI questionnaire and the performance-based tests
have to be considered. Firstly, self-reported measures
such as the BASFI questionnaire incorporate multiple
aspects relating to physical function such as time to
complete a task and exertion and pain experienced dur-
ing activities, whereas performance-based tests primarily
measure time to complete a task. Additionally, self-
reported measures are influenced by psychological fac-
tors. Recent findings by Brionez et al. [28] support this.
They found that in patients with AS helplessness,
depression and passive coping accounted for significant
variability in self-reported functional limitations as mea-
sured with the BASFI questionnaire. They advised that
psychological health should be examined and accounted
for when assessing functional status in AS patients [28].
Psychological health was not measured in our cohort of
AS patients, and could therefore not be taken into
account when interpreting our results. Secondly,
Table 2 Univariable and multivariable associations of
performance-based tests with the BASFI questionnaire
(tests 1 to 6 and 8 together, test 7 separate) (n = 126)
Tests 1 to 6 plus 8 R-square Beta P value
Univariable 0.31 Performance 0.56 0.000
Multivariable 0.54 Performance 0.19 0.018
Exertion 0.38 0.000
Pain 0.26 0.008
Test 7
Univariable 0.39 Performance 0.63 0.000
Multivariable 0.51 Performance 0.49 0.000
Exertion 0.00 0.991
Pain 0.36 0.001
Tests: 1) climbing stairs, 2) bending, 3) reaching up, 4) putting on socks, 5)
reclining and declining from a chair, 6) getting up from the floor, 7) looking
over the shoulder, 8) physically demanding activity. BASFI, Bath Ankylosing
Spondylitis Functional Index.
Table 3 Associations of performance-based tests with the
BASDAI questionnaire and BASMI (tests 1 to 6 plus 8
together, test 7 separate) (n = 126)
Tests 1 to 6 plus 8 R-square Beta P value
BASDAI 0.08 0.28 0.002
BASMI (n = 98) 0.24 0.50 0.000
Test 7
BASDAI 0.00 -0.06 0.534
BASMI (n = 97) 0.60 0.77 0.000
Tests: 1) climbing stairs, 2) bending, 3) reaching up, 4) putting on socks, 5)
reclining and declining from a chair, 6) getting up from the floor, 7) looking
over the shoulder, 8) physically demanding activity. BASDAI, Bath Ankylosing
Spondylitis Disease Activity Index; BASMI, Bath Ankylosing Spondylitis
Metrology Index.
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discrepancies in the association between performance-
based tests and the BASFI questionnaire may occur due
to underestimation of limitations in physical function.
Patients with longer disease duration may tolerate more
limitations in physical function and adapt to a certain
amount of declining function. Thirdly, the association
between performance-based physical function and the
BASFI questionnaire is influenced by the reliability of
these measures [14]. We previously showed that the
reliability of the performance-based measures is good
[22] and equivalent with the BASFI questionnaire
[3,6,8]. However, due to the lack of perfect reliability,
the maximal obtainable association between perfor-
mance-based measures and the BASFI questionnaire is
limited.
We showed that not all performance items belong to
the same domain. Performance items no. 1 to 6 and 8
(stair climbing, bending, reaching, putting on socks,
reclining and declining from a chair, getting up from
the floor and doing a physically demanding activity)
seem to belong to one domain as opposed to looking
over the shoulder. This may be due to the fact that
items 1 to 6 and 8 are activities that concern complex
movements by which the heart rate may increase and
stamina, muscle power and coordination are necessary,
whereas item 7 (looking over the shoulder) is an isolated
movement of the cervical spine that refers to an impair-
ment in mobility.
The results from this study also show that perfor-
mance-based physical function is associated with
impaired mobility of the spine and hip due to structural
changes (as measured by the BASMI). Although related,
both concepts are not equivalent. In the BASMI the
range of motion in a static position is measured.
Whereas, performance-based physical function is estab-
lished by the timing of a daily activity comprising of
complex movements. Executing an activity such as
standing up from the floor will be affected by an
impaired mobility of the spine and hip, but also by mus-
cular strength, stamina and coordination. The sum of
these properties seems to be measured by a perfor-
mance-based test. Disease activity as measured with the
BASDAI was only weakly related to performance-based
physical function.
In our opinion, two study limitations warrant further
consideration. Firstly, the BASFI and the performance-
based tests were completed within one month, with the
assumption that patients had an unchanged physical
condition in this period. Variability in disease activity
for example might have influenced physical condition
between both measurement points. A study by Berthelot
et al. in spondylarthropathy patients indicated that
BASFI scores often show variations over time in a given
patient [29]. However, these variations concerned self-
reported physical function, and do not correspond with
our previous findings regarding the reliability of perfor-
mance-based physical function measures over time [22].
In addition, mean disease duration was 14.7 years and
most patients were stable on medication. As changes in
physical function take time to develop, it is unlikely that
major changes in physical function within only a one-
month period have occurred. Therefore, the influence of
therapy and timing on the completion of the BASFI
questionnaire and performance-based tests on our
results is expected to be only marginal.
Secondly, the time of day at which the tests were per-
formed could have influenced our results. When asses-
sing early in the morning or late in the afternoon
patients could have had more difficulty performing tests
due to morning stiffness or fatigue for example. How-
ever, patients could choose the time of the assessment,
therefore it is not likely that this played a big role.
For future research, additional data on the responsive-
ness to interventions, such as the start of TNF blockers,
have to be established. Another focus for future research
is to select a group of performance-based tests, generat-
ing the equivalent information as the full set, which is
feasible for use in daily clinical practice. To improve the
feasibility of the performance-based tests in daily clinical
practice adaptations to the scoring method could be
considered.
Conclusions
To conclude, this study clearly demonstrates that asso-
ciations between performance-based measures of physi-
cal function and the BASFI questionnaire are moderate.
Alongside actual performance, patients seem to incorpo-
rate exertion and pain in their assessment of perceived
physical function on the BASFI questionnaire. Perfor-
mance-based tests could provide an objective outcome
measurement for the evaluation of physical function and
give relevant new information in addition to the BASFI
questionnaire.
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